期刊文献+

端粒、端粒长度、端粒酶活性与卵巢癌发生的关系 被引量:1

下载PDF
导出
摘要 端粒长度、端粒酶活性与细胞无限增殖密切相关,已成为肿瘤学研究领域的一个热点。本文对端粒结构、端粒长度、端粒酶活性与卵巢癌发生的关系作一综述。
出处 《中国医学文摘(肿瘤学)》 2005年第4期333-334,336,共3页 Journal of Chinese Medical Abstracts·Oncology
  • 相关文献

参考文献11

  • 1Atsuo Nakamura,Takeshi Suda,Terasu Honma,Toru Takahashi,Masato Igarashi,Nobuo Waguri,Hirokazu Kawai,Yusaku Mita,Yutaka Aoyagi.Increased hTR Expression During Transition from Adenoma to Carcinoma Is Not Associated with Promoter Methylation[J].Digestive Diseases and Sciences.2004(9)
  • 2Shay J W,Bacchetti S.A survey of telomerase activity in human cancer[].European Journal of Cancer.1997
  • 3Wick M,Zubov D,Hagen G,et al.Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT)[].Gene.1999
  • 4Satoru K,Masahiro T,Takahiro T,et al.Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT)[].Nucleic Acids Research.2000
  • 5Murakami J,Nagai N,Ohama K,et al.Telomerase activity in ovarian tumors[].Cancer.1997
  • 6Kiyozuka Y,Yamamoto D,Yang J,et al.Correlation of chemosensitivity to anticancer drugs and telomere length, telomerase activity and telomerase RNA expression in human ovarian cancer cells[].Anticancer Research.2000
  • 7Park T W,Riethdorf S,Riethdorf L,et al.Differential telomerase activity, expression of the telomerase catalytic subunit and telomerase-RNA in ovarian tumors[].International Journal of Cancer.1999
  • 8Wisman G B,Hollema H,Helder M N,et al.Telomerase in relation to expression of p53, c-myc and estrogen receptor in ovarian tumours[].International Journal of Oncology.2003
  • 9Wan M H,Li W Z,Duggan B D,et al.Telomerase activity in benign and malignant epithelial ovarian tumors[].Journal of the National Cancer Institute.1997
  • 10Kyo S,Takakura M,Tanaka M,et al.Quantitative differences in telomerase activity among malignant, premalignant and benign ovarian lesions[].Clinical Cancer Research.1998

同被引文献10

  • 1李雪梅,姚嘉斐.端粒酶与卵巢癌[J].实用妇产科杂志,2005,21(3):147-150. 被引量:3
  • 2郝建军,刘桂成.端粒酶活性检测在直肠癌诊断中的应用[J].河北职工医学院学报,2005,22(4):33-34. 被引量:1
  • 3VAN DALEN A,FAVIER J, BURGES A, et al. Prognostic significance of CA125 and TPS levels after 3 chemotherapy courses in ovarian cancer patients [J]. Gynecol Oncol, 2000, 79 (3):444-450.
  • 4KIM NW, WEIRICH SL. Detection of telomerase activity in human ceils and tumors by a telomeric repeat amplification protocol (TRAP)[J]. Method Cell Sci, 1995, 17:1.
  • 5BREMER K, EKLUND G, BJORKLUND B. Notable relationship between the level of tumor marker TPS in serum and survival in breast cancer[J]. Anticancer Res, 1996, 16: 905-909.
  • 6PIATYSZEK MA, CUPTA J. Human telomere RNA and telomerase activity in immortal cell lines and tumor tissues [J]. Cancer Res, 1996, 56: 645-648.
  • 7KIM NW, PIATYSZEK MA, PROWSE KR, et al. Specific association of human telomerase activity with immortal cells and cancer [J]. Science, 1994, 266: 2011-2015.
  • 8KIMURA M, KOIDA T. YANAGITA Y. A study on telomerase activity and prognosis in breast cancer [J]. Med Oncol, 2003, 20: 117-126.
  • 9LAM KY, LAW S, LUK JM, et al. Oesophageaf basaloid souamous cell carcinoma: a unique cinicopathological entity with telomerase activity as a prognostic indicator [J]. Pathol, 2001, 195: 435-442.
  • 10李军,罗秋波,苗爱莲,魏署亚,王香林,唐爱霞.血清TPS和CA15-3水平变化与乳腺癌的关系及其临床意义[J].实用癌症杂志,2002,17(2):175-177. 被引量:13

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部